VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM
VYNE Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.96 | -2.97 | -1.65 | -2.18 | -5.25 | -2.92 | -0.5 | -0.33 | -0.45 | -0.26 | -0.34 | -0.66 | 1.93 | -1.18 | -0.85 | -2.26 | -4.07 |
PEG Ratio | 0.07 | 0.86 | -0.05 | -0.05 | 0.21 | 0.03 | 0.01 | -0.00 | 0.01 | 0.02 | -0.03 | 0.00 | -0.01 | 0.03 | -0.16 | 0.29 | 0.36 |
PS Ratio | 333.78 | 1.7K | 661.68 | 412.96 | 1.34K | 951.93 | 116.24 | 99.31 | 101.42 | 1.34K | 77.27 | 178.78 | 202.25 | 23.82 | 17.70 | 42.38 | 81.21 |
PB Ratio | 1.53 | 2.74 | 1.26 | 1.09 | 1.57 | 0.82 | 1.15 | 0.78 | 0.38 | 0.26 | 0.32 | 0.47 | 0.65 | 1.12 | 1.23 | 2.41 | 3.60 |
P/FCF Ratio | -5.88 | -15.65 | -9.41 | -9.64 | -16.43 | -14.08 | -2.57 | -1.4 | -1.83 | -2.08 | -1.81 | -2.74 | -3.61 | -5.45 | -4.12 | -11.1 | -26.65 |
P/OCF Ratio | -5.88 | -15.85 | -9.41 | -9.64 | -16.43 | -14.08 | -2.57 | -1.4 | -1.83 | -2.08 | -1.81 | -2.74 | -3.61 | -5.45 | -4.12 | -11.1 | -26.65 |
OCF/S Ratio | -56.74 | -107.13 | -70.33 | -42.83 | -81.45 | -67.59 | -45.19 | -70.92 | -55.33 | -645.83 | -42.66 | -65.28 | -56.04 | -4.37 | -4.29 | -3.82 | -3.05 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a | -0.01 | n/a | 0.00 | 0.00 | 0.01 | 0.02 | 0.46 | 0.37 |
Quick Ratio | 4.47 | 4.35 | 5.81 | 7.13 | 13.02 | 12.73 | 2.71 | 3.59 | 4.39 | 4.09 | 6.43 | 7.60 | 6.54 | 3.04 | 3.24 | 2.09 | 6.27 |
Current Ratio | 4.47 | 4.35 | 5.81 | 7.13 | 13.02 | 12.73 | 2.72 | 3.60 | 4.39 | 4.10 | 6.44 | 7.60 | 7.06 | 3.43 | 3.63 | 2.23 | 6.64 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.03 | 0.03 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -25.98 | n/a | n/a | n/a | -3.41 | n/a | n/a | -2.9K | n/a | 5.12 | -17.49 | -18.3 |
Return on Equity | -0.2 | -0.23 | -0.19 | -0.13 | -0.07 | -0.07 | -0.57 | -0.58 | -0.21 | -0.25 | -0.24 | -0.18 | 0.08 | -0.24 | -0.36 | -0.27 | -0.22 |
Return on Assets | -0.15 | -0.18 | -0.16 | -0.11 | -0.07 | -0.06 | -0.34 | -0.4 | -0.16 | -0.19 | -0.2 | -0.15 | 0.07 | -0.17 | -0.26 | -0.15 | -0.14 |
Return on Invested Capital | -0.19 | -0.24 | -0.21 | -0.14 | -0.09 | -0.08 | -0.53 | -0.56 | -0.21 | -0.25 | -0.24 | -0.18 | 0.08 | -0.24 | 0.34 | -0.18 | -0.16 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.95 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.90 | 1.00 | 0.61 | 0.74 | 0.81 | 0.85 |
Net Profit Margin | -42.63 | -143.12 | -100.47 | -47.45 | -63.68 | -81.42 | -57.75 | -74.5 | -56.79 | -1.29K | -56.64 | -67.27 | 26.24 | -5.05 | -5.21 | -4.68 | -4.99 |
Pretax Profit Margin | -42.59 | -142.98 | -100.47 | -47.45 | -63.68 | -80.95 | -53.25 | -74.36 | -56.69 | -1.29K | -55.42 | -65.36 | -48.84 | -5.24 | -5.21 | -4.68 | -4.99 |
Operating Profit Margin | -42.59 | -152.02 | -108.19 | -52.51 | -75.31 | -89.89 | -54.68 | -76.43 | -59.34 | -1.33K | -55.89 | -65.77 | -48.83 | -5.25 | 4.35 | -4.41 | -4.72 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -42.59 | -152.02 | -108.19 | -47.45 | -75.31 | -89.89 | -54.68 | -74.36 | -59.34 | -1.29K | -54.86 | -65.67 | -48.6 | -5.23 | -2.64 | -4.42 | -4.72 |